TY - JOUR
T1 - Comparison of myoglobin clearance in three types of blood purification modalities
AU - Suzuki, Shinya
AU - Moriyama, Kazuhiro
AU - Hara, Yoshitaka
AU - Hinoue, Takuya
AU - Kato, Yu
AU - Hasegawa, Daisuke
AU - Kuriyama, Naohide
AU - Nakamura, Tomoyuki
AU - Komatsu, Satoshi
AU - Yamashita, Chizuru
AU - Komura, Hidefumi
AU - Nishida, Osamu
N1 - Publisher Copyright:
© 2021 International Society for Apheresis, Japanese Society for Apheresis, and Japanese Society for Dialysis Therapy.
PY - 2021/8
Y1 - 2021/8
N2 - Myoglobin, which can cause acute kidney injury, has a relatively high molecular weight and is poorly cleared by diffusion. We compared and examined myoglobin clearance by changing the blood purification membrane and modality in patients with a myoglobin blood concentration ≥ 1000 ng/ml. We retrospectively analyzed three patient groups based on the following three types of continuous hemofiltration (CHF): AN69ST membrane, polymethylmethacrylate (PMMA) membrane, and high-flow hemodiafiltration (HDF) with increased dialysate flow rate using the PMMA membrane. There was no significant difference in clearance in CHF between AN69ST and PMMA membranes. However, the high-flow HDF group showed the highest myoglobin clearance (p = 0.003). In the PMMA membrane, changing the treatment modality to high-flow HDF increased clearance above the theoretical value, possibly due to internal filtration. To remove myoglobin by kidney replacement therapy from patients with hypermyoglobinemia, a modality such as high-flow HDF would be desirable.
AB - Myoglobin, which can cause acute kidney injury, has a relatively high molecular weight and is poorly cleared by diffusion. We compared and examined myoglobin clearance by changing the blood purification membrane and modality in patients with a myoglobin blood concentration ≥ 1000 ng/ml. We retrospectively analyzed three patient groups based on the following three types of continuous hemofiltration (CHF): AN69ST membrane, polymethylmethacrylate (PMMA) membrane, and high-flow hemodiafiltration (HDF) with increased dialysate flow rate using the PMMA membrane. There was no significant difference in clearance in CHF between AN69ST and PMMA membranes. However, the high-flow HDF group showed the highest myoglobin clearance (p = 0.003). In the PMMA membrane, changing the treatment modality to high-flow HDF increased clearance above the theoretical value, possibly due to internal filtration. To remove myoglobin by kidney replacement therapy from patients with hypermyoglobinemia, a modality such as high-flow HDF would be desirable.
UR - http://www.scopus.com/inward/record.url?scp=85105133844&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85105133844&partnerID=8YFLogxK
U2 - 10.1111/1744-9987.13657
DO - 10.1111/1744-9987.13657
M3 - Article
C2 - 33886132
AN - SCOPUS:85105133844
SN - 1744-9979
VL - 25
SP - 401
EP - 406
JO - Therapeutic Apheresis and Dialysis
JF - Therapeutic Apheresis and Dialysis
IS - 4
ER -